Thermalin Diabetes' Unattributed Round

Thermalin Diabetes raised a round of funding on July 30, 2014. Investors include Cleveland Economic Development.

Thermalin is pursuing promising product profiles that will improve insulin therapy for specific classes of patients and enable new delivery technologies. These include: Ultra-concentrated (U500) insul…

Articles about Thermalin Diabetes' Unattributed Round: